
Delcath Systems Inc (DCTH) Dividend History
Delcath Systems Inc (DCTH) is a healthcare company specializing in innovative, proprietary targeted drug delivery systems for the treatment of cancer. Their flagship product, the HEPATIC CHEMOSAT Delivery System, is designed to deliver high doses of chemotherapy directly to the liver, aiming to improve treatment outcomes for hepatic cancers. The company focuses on developing and commercializing therapies that enhance the efficacy of chemotherapy while minimizing systemic side effects.
Dividend History
Delcath Systems Inc currently does not pay dividends
Company News
-
Zacks Investment Research
-
Zacks Investment Research
-
Zacks Investment Research
-
Wall Street Analysts Predict a 201.72% Upside in Delcath Systems (DCTH): Here's What You Should KnowZacks Investment Research
-
Zacks Investment Research